Jasper Therapeutics JSPR
Jasper Therapeutics: preliminary proxy statement
- Form
- PRE 14A
- Filed
- Importance
- Routine
- Accession
- 0001213900-26-093145
Not explained yet; the original is on EDGAR.
Preliminary proxy statement
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025
- Macrogenics MGNX public float $74M, Jun 30, 2025
- Volitionrx VNRX public float $73M, Jun 30, 2025
- XBiotech XBIT public float $77M, Jun 30, 2025
- Gyre Therapeutics GYRE public float $73M, Jun 30, 2025